Listen Get

The Oxford RECOVERY Trial

Keywords

war-on-disease, 1-percent-treaty, medical-research, public-health, peace-dividend, decentralized-trials, dfda, dih, victory-bonds, health-economics, cost-benefit-analysis, clinical-trials, drug-development, regulatory-reform, military-spending, peace-economics, decentralized-governance, wishocracy, blockchain-governance, impact-investing

The Oxford RECOVERY trial isn’t theory. It’s proof.

In 2020, Oxford spent $500 (95% CI: $400-$2,500) per patient1. Traditional trials cost $41,000 (95% CI: $20,000-$120,000). RECOVERY saved over 1 million lives2. That’s an 82x (90% CI: 21.4x-195x) efficiency gain.

Metric RECOVERY U.S. Average
Conception to first patient 9 days3 6-12 months4
First life-saving result 100 days5 6-10 years6
Cost per life saved $2,700 Often never saves any lives

Pragmatic vs Traditional Trials

Metric Pragmatic (e.g., RECOVERY) Traditional Explanatory Trials
Cost per Patient

$500 (95% CI: $400-$2,500)

$41,000 (95% CI: $20,000-$120,000)
Time to Results Weeks to months 5-7 years average
Participants Large (49,000+ in RECOVERY) Typically 500-3,000
Implementation Speed Hours to days Months to years
Patient Population Diverse, real-world Highly selected
Setting Routine clinical practice Specialized research centers
Generalizability High Limited

Key RECOVERY Trial Statistics

Metric Value Source
Total Patients Enrolled 49,000+ RECOVERY Trial Website7
Participating Hospitals 186 RECOVERY Trial Website7
Total Trial Cost £2.1M (~$2.7M) UKRI Impact Report8
Cost per Patient ~$500 (95% CI: $400-$2,500)9 Manhattan Institute9
Traditional Trial Cost per Patient ~$41,000 (95% CI: $20,000-$120,000) NCBI1
Treatments Evaluated 12 RECOVERY Results10
Cost per Intervention ~£175,000 (~$223,000) Calculated (£2.1M ÷ 12 treatments)
Proven Effective Treatments 4 Nuffield Department of Population Health11
UK Lives Saved (by March 2021) 22,000+ UKRI Impact Report8
Global Lives Saved (by March 2021) 1,000,000+ UKRI Impact Report8
Days to First Major Result <100 The Conversation12

The RECOVERY trial enrolled 49,000 patients across 186 hospitals, tested 12 treatments, saved a million lives, and cost less than a single F-35 fighter jet.

The UK spent $500 per patient and saved one million lives. America spends $41,000 per patient. This is an 82-times-worse deal that kills people by costing too much.

The UK spent $500 per patient and saved one million lives. America spends $41,000 per patient. This is an 82-times-worse deal that kills people by costing too much.

How? Five obvious things:

They Used Regular Hospitals

No specialized research centers. No gold-plated equipment. Just regular hospitals with regular doctors treating regular patients.

Traditional trials build special buildings with special doctors for special patients. RECOVERY used the hospital that was already there with the doctors and patients already inside it.

Traditional trials build special buildings with special doctors for special patients. RECOVERY used the hospital that was already there with the doctors and patients already inside it.

They Collected Only Useful Data

The trial focused on core outcomes: “Did the patient live or die? Did they get better or worse?”

Old way: mountains of paper and vials. New way: one form. The difference is someone asked if the paper was necessary.

Old way: mountains of paper and vials. New way: one form. The difference is someone asked if the paper was necessary.

No seventeen-page questionnaires about quality of life. No daily blood draws for biomarkers nobody understands. Just: “Did it work?”

They used existing hospital data. One standardized form. Done.

They Integrated With Normal Care

Patients got the experimental treatment during regular care. No separate facility. No hovering clipboard researchers. Just normal doctors, except some patients got the experimental drug.

In the old model, sick people travel to a special building to get experimental medicine. In the new model, they get it from their regular doctor during their regular visit at their regular hospital.

In the old model, sick people travel to a special building to get experimental medicine. In the new model, they get it from their regular doctor during their regular visit at their regular hospital.

Turns out this works fine. Who knew.

They Were Flexible

When a treatment didn’t work, they stopped testing it. When a new promising treatment emerged, they added it.

FDA trials work like a factory assembly line. RECOVERY worked like a kitchen where you can taste the soup while it’s cooking and add more salt.

FDA trials work like a factory assembly line. RECOVERY worked like a kitchen where you can taste the soup while it’s cooking and add more salt.

The FDA would require a completely new trial for each change. RECOVERY just… changed. Like adults making decisions.

They Prioritized Speed Over Bureaucracy

RECOVERY answered important clinical questions quickly using existing infrastructure.

RECOVERY wanted to know if the drug worked and wanted to know fast. The FDA wanted to know if you filled out the forms correctly.

RECOVERY wanted to know if the drug worked and wanted to know fast. The FDA wanted to know if you filled out the forms correctly.

The FDA prioritizes paperwork over questions, bureaucracy over speed, and process over results.

The Result

$500 (95% CI: $400-$2,500) vs the U.S. average of $41,000 (95% CI: $20,000-$120,000)1.

$500 versus $41,000 to ask the same question. One country used hospitals. The other country used bureaucracy. Bureaucracy costs 82 times more.

$500 versus $41,000 to ask the same question. One country used hospitals. The other country used bureaucracy. Bureaucracy costs 82 times more.

That’s an 82x (90% CI: 21.4x-195x) efficiency gain achieved by doing the obvious things in obvious ways.

Also, they saved a million lives by determining that steroids work on severe COVID within 100 days.

A trial following traditional timelines would likely still be in its early phases.

What RECOVERY Proved

Six things RECOVERY proved:

  1. Decentralization works. 186 hospitals. Better results than centralized control.
  2. Real patients matter. Traditional U.S. trials exclude the sickest people13. RECOVERY included them.
  3. Speed saves lives. 100 days to first result. Traditional: years.
  4. Cost is a choice. The 82x (90% CI: 21.4x-195x) gap is bureaucracy, not capability.
  5. Scale is achievable. 49,000 patients enrolled faster than most U.S. trials enroll 1,00014.
  6. Simplicity wins. Three 1-page forms vs. FDA’s multi-form protocols15.

RECOVERY: cheap, fast, huge. Traditional U.S. trials: expensive, slow, small. These are opposites. One saved a million lives.

RECOVERY: cheap, fast, huge. Traditional U.S. trials: expensive, slow, small. These are opposites. One saved a million lives.

Cost Per Medical Answer

  • RECOVERY: $50 per patient per answer (10 treatments, 49,000 patients)
  • Traditional U.S. trials: $41,000 per patient, usually testing one treatment
  • 820x efficiency gain per medical answer

$41,000 to answer a question the traditional way. $50 to answer it the RECOVERY way. You could answer 820 questions for the price of one. You answer one.

$41,000 to answer a question the traditional way. $50 to answer it the RECOVERY way. You could answer 820 questions for the price of one. You answer one.

You know how to do this 82x (90% CI: 21.4x-195x) more efficiently. Oxford proved it. The question is whether you scale it or keep spending $41,000 per patient while people die waiting.

Sources

Cost: Total trial cost was £2.1M (~$2.7M). Funded jointly by UKRI and NIHR as part of a £20M rapid research response.8

Impact: Dexamethasone alone saved ~22,000 lives in the UK and 1 million globally by March 2021. Three groundbreaking results within 100 days. Four proven treatments total (dexamethasone, tocilizumab, Ronapreve, baricitinib). (UKRI8, Nuffield11)

Scale: 40,000+ participants across 185 sites. World’s largest COVID treatment trial.8

Cost per patient: Simple division gives ~£43 (~$55). Authoritative sources cite ~$500 (95% CI: $400-$2,500)9. A systematic review of 64 pragmatic trials found a median of $97 (95% CI: $19-$478)/patient16. Either way: nearly 82x (90% CI: 21.4x-195x) cheaper than traditional trials at $41,000 (95% CI: $20,000-$120,000)1.

500 per patient, 40,000 patients, one million lives saved. Traditional trials spend $41,000 per patient and save far fewer lives. The British discovered that waste is expensive.

500 per patient, 40,000 patients, one million lives saved. Traditional trials spend $41,000 per patient and save far fewer lives. The British discovered that waste is expensive.

Scaling RECOVERY’s Model

Centralized: patients come to the data. Decentralized: data comes to the patients. One requires patients to travel. The other requires the internet.

Centralized: patients come to the data. Decentralized: data comes to the patients. One requires patients to travel. The other requires the internet.

Apply RECOVERY’s approach to all drug development:

$2.2 billion to develop a drug the traditional way. $27 million to do it the RECOVERY way. That’s an 82-times discount for using common sense.

$2.2 billion to develop a drug the traditional way. $27 million to do it the RECOVERY way. That’s an 82-times discount for using common sense.